An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features

Human Pathology

Volumn 39, Issue 12, 2008, Pages 1854-1858

  Chen, Sung Ting ^a   Lee, Jen Chieh ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ALK; Inflammatory myofibroblastic tumor; RANBP2; Round cell transformation

Indexed keywords

ADULT; ALK GENE; ARTICLE; CASE REPORT; CELL STRUCTURE; CELL TRANSFORMATION; CLINICAL FEATURE; GENE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER TUMOR; MALE; MORPHOLOGY; PLASMA CELL GRANULOMA; PROGNOSIS; RANBP2 GENE; SYMPTOM; WEIGHT REDUCTION;

ADULT; BASE SEQUENCE; FATAL OUTCOME; FIBROBLASTS; GENE REARRANGEMENT; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MUSCLE TISSUE; NUCLEAR PORE COMPLEX PROTEINS; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 55949085102     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.04.016     Document Type: Article

References (13)

1. Coffin C.M., and Fletcher J.A. Inflammatory myofibroblastic tumour. In: Fletcher C.D.M., Unni K., and Mertens F. (Eds). Pathology and genetics of tumours of soft tissue and bone. World Health Organization classification of tumours (2002), IARC Press, Lyon 91-93
2. Cook J.R., Dehner L.P., Collins M.H., et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 25 (2001) 1364-1371
3. Ma Z., Hill D.A., Collins M.H., et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 37 (2003) 98-105
4. Patel A.S., Murphy K.M., Hawkins A.L., et al. RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet 176 (2007) 107-114
5. Debiec-Rychter M., Marynen P., Hagemeijer A., et al. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 38 (2003) 187-190
6. Cools J., Wlodarska I., Somers R., et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 34 (2002) 354-362
7. Li X.Q., Hisaoka M., Shi D.R., Zhu X.Z., and Hashimoto H. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases. Hum Pathol 35 (2004) 711-721
8. Panagopoulos I., Nilsson T., Domanski H.A., et al. Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. Int J Cancer 118 (2006) 1181-1186
9. Yamamoto H., Kohashi K., Oda Y., et al. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. Pathol Int 56 (2006) 584-590
10. Chan J. Proliferative lesions of follicular dendritic cells: an overview, including a detailed account of follicular dendritic cell sarcoma, a neoplasm with many faces and uncommon etiologic associations. Adv Anat Pathol 4 (1997) 387-411
11. Cessna M.H., Zhou H., Sanger W.G., et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Mod Pathol 15 (2002) 931-938
12. Hussong J.W., Brown M., Perkins S.L., et al. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors. Mod Pathol 12 (1999) 279-286
13. Coffin C.M., Hornick J.L., and Fletcher C.D. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 31 (2007) 509-520